A 2019 literature review summarizes the finding on using THC and CBD on patients with dementia. Researchers found that Dronabinol and THC were associated with significant improvements in a range of psychiatric scores. Interestingly, cannabis products showed the most promising results in patients whose symptoms were previously unmanageable or resistant to other treatments. |

View this review (yellow link) or download:
Safety and effectiveness of cannabinoids for the treatment of neuropsychiatric symptoms in dementia- a systematic reviewDownload
This paper is also stored here: http://bit.ly/2IWFA8R inside the CED Foundation Archive
To explore related information, click the keywords below: